Table 8.
Recommendations | Class I LOE |
---|---|
2-vessel or 3-vessel disease with significant proximal LAD lesions, with anatomy enabling catheter-based therapy and normal LVF; diabetics under treatment excluded. | I (B) |
1-vessel or 2-vessel disease without significant proximal LAD lesions, with high risk on noninvasive testing and a large area of viable myocardium. | I (B) |
Prior PCI with either recurrence of stenosis or high risk on noninvasive testing. | I (C) |
Failure of optimum medical therapy and with acceptable risk for revascularization procedure. | I (B) |
Abbreviations: ACC/AHA, American College of Cardiology/American Heart Association; PCI, percutaneous coronary intervention; LOE, level of evidence; LAD, left anterior descending coronary artery; LVF, left ventricular function.